Kirschbaum Mark 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-13+100,000→ 100,000 totalExercise: $3.45Exp: 2031-12-13→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted as part of the Issuer's annual compensation review to executive officers.